At-Home Flu ‘Shot’ Available Next Year

The Food and Drug Administration recently approved a nasally-administered influenza immunization treatment that can be taken at home. FluMist, a nasal spray vaccine developed by AstraZeneca, will now be available for prescription purchase through an online pharmacy starting next year, as reported by The New York Times.

Convenient Home Administration

To obtain FluMist, individuals will need to fill out a questionnaire on the upcoming FluMist Home website. After approval by a pharmacist, the nasal spray will be shipped directly to the customer’s door. The cost currently ranges from $35 to $45 per dose, although this price may vary based on insurance coverage.

Efficient and Effective Treatment

Research by the Centers for Disease Control and Prevention has shown that FluMist is as effective as the traditional flu shot. This nasal spray has been available through healthcare providers since its initial FDA approval in 2003. While suitable for individuals aged 2 to 49, it’s recommended that children under 18 have the spray administered by a parent or caregiver. This alternative is ideal for those who prefer not to get injections or struggle with access to in-person flu immunization services.

Public Health Impact and Recommendations

Dr. Peter Marks, director of the FDA’s vaccine center, expressed optimism about the approval of the first self-administered influenza vaccine. He highlighted the potential for increased convenience, flexibility, and accessibility for individuals and families. According to the World Health Organization, seasonal influenza leads to millions of cases and respiratory deaths annually.

Conclusion

In conclusion, the approval of at-home administration of the FluMist nasal spray offers a convenient and effective option for flu immunization. With potential cost savings and increased accessibility, this innovation could have a positive impact on public health efforts to combat seasonal influenza.

FAQs

Q: Is FluMist suitable for all ages?

A: FluMist is recommended for individuals aged 2 to 49, with children under 18 advised to have it administered by a parent or caregiver.

Q: What is the cost of FluMist?

A: The current out-of-pocket cost for FluMist ranges from $35 to $45 per dose, which may vary based on insurance coverage.

Credit: www.theverge.com